Pictured: A boy sitting in a wheelchair on a beach/iStock, ChiccoDodiFC The FDA on Thursday approved Santhera Pharmaceuticals’ new corticosteroid vamorolone, now marketed under the brand name Agamree, for the treatment of Duchenne muscular dystrophy. The announcement was made by Florida-based Catalyst Pharmaceuticals, which paid $90 million upfront in June 2023 and pledged up to …
Pictured: A woman scratches skin lesions on her elbow/iStock, helivideo The FDA on Wednesday approved UCB’s bimekizumab for the treatment of adults with moderate to severe plaque psoriasis. The treatment will be sold under the Bimzelx brand. Bimzelx is a humanized IgG1 monoclonal antibody that acts by targeting IL-17A and IL-17F, two central players in …
TOP LINE: There is a graded positive association between depressive symptoms and mortality among adults, a finding that researchers say supports the development of a comprehensive national strategy to improve mental and physical health. METHODOLOGY: Researchers analyzed data from 23,694 adults (mean age, 44 years; 50% men) from the National Health and Nutrition Examination Survey …